Drug Industry Middlemen To Be Questioned By Senate Committee
The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.
leia mais em NPR
No comments:
Post a Comment